Litcius/Paper detail

Progressive Desmoid Tumor: Radiomics Compared With Conventional Response Criteria for Predicting Progression During Systemic Therapy—A Multicenter Study by the French Sarcoma Group

Amandine Crombé, Michèle Kind, Isabelle Ray‐Coquard, Nicolás Isambert, Christine Chevreau, Thierry André, Célèste Lebbé, Axel Le Cesne, Emmanuelle Bompas, Sophie Piperno‐Neumann, Esma Saâda, Amine Bouhamama, Jean‐Yves Blay, Antoîne Italiano, for the French Sarcoma Group

2020American Journal of Roentgenology38 citationsDOI

Abstract

Quantifying early changes in heterogeneity through a dedicated radiomics score could improve response evaluation for patients with DT undergoing chemotherapy.

Topics & Concepts

MedicineRadiomicsSarcomaMulticenter studyTumor progressionSystemic therapyInternal medicinePathologyRadiologyCancerRandomized controlled trialBreast cancerSoft tissue tumor case studiesSarcoma Diagnosis and TreatmentSoft tissue tumors and treatment
Progressive Desmoid Tumor: Radiomics Compared With Conventional Response Criteria for Predicting Progression During Systemic Therapy—A Multicenter Study by the French Sarcoma Group | Litcius